| Protein | Synonyms | Taxonomy |
|---|---|---|
| Renin | EC 3.4.23.15; Angiotensinogenase | Homo sapiens (human) |
| Sodium/potassium-transporting ATPase subunit beta-1 | Sodium/potassium-dependent ATPase subunit beta-1 | Homo sapiens (human) |
| Sodium/potassium-transporting ATPase subunit alpha-4 | Na(+)/K(+) ATPase alpha-4 subunit; EC 7.2.2.13; Sodium pump subunit alpha-4 | Homo sapiens (human) |
| Sodium/potassium-transporting ATPase subunit alpha-1 | Na(+)/K(+) ATPase alpha-1 subunit; EC 7.2.2.13; Sodium pump subunit alpha-1 | Homo sapiens (human) |
| Sodium/potassium-transporting ATPase subunit alpha-3 | Na(+)/K(+) ATPase alpha-3 subunit; EC 7.2.2.13; Na(+)/K(+) ATPase alpha(III) subunit; Sodium pump subunit alpha-3 | Homo sapiens (human) |
| Sodium/potassium-transporting ATPase subunit beta-2 | Adhesion molecule in glia; AMOG; Sodium/potassium-dependent ATPase subunit beta-2 | Homo sapiens (human) |
| Sodium/potassium-transporting ATPase subunit alpha-2 | Na(+)/K(+) ATPase alpha-2 subunit; EC 7.2.2.13; Sodium pump subunit alpha-2 | Homo sapiens (human) |
| Sodium/potassium-transporting ATPase subunit beta-3 | Sodium/potassium-dependent ATPase subunit beta-3; ATPB-3 | Homo sapiens (human) |
| Sodium/potassium-transporting ATPase subunit gamma | Na(+)/K(+) ATPase subunit gamma; FXYD domain-containing ion transport regulator 2; Sodium pump gamma chain | Homo sapiens (human) |
| Chloride channel protein ClC-Ka | Chloride channel Ka; ClC-K1 | Homo sapiens (human) |
| Solute carrier family 12 member 1 | Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2; Kidney-specific Na-K-Cl symporter | Homo sapiens (human) |
| Solute carrier family 12 member 6 | Electroneutral potassium-chloride cotransporter 3; K-Cl cotransporter 3 | Homo sapiens (human) |
| Sodium/potassium-transporting ATPase subunit beta | Homo sapiens (human) |
| Compound | Description |
|---|---|
| angiotensin ii | An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. |
| chlorine | An element with atomic symbol Cl, atomic number 17, and atomic weight 35, and member of the halogen family. |
| potassium | An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE. |
| Sodium | A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. |
| angiotensin i, ile(5)- |